Increased chemosensitivity and elevated reactive oxygen species are mediated by glutathione reduction in glutamine deprived neuroblastoma cells

Journal of Cancer Research and Clinical Oncology

Volumn 134, Issue 7, 2008, Pages 761-768

  Izaki, Sakurako ^a   Goto, Hiroaki ^a   Yokota, Shumpei ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Chemosensitivity; Glutamine; Glutathione (GSH); Hypoxia; L PAM; Neuroblastoma; Oxidative stress

Indexed keywords

GLUTAMINE; GLUTATHIONE; MELPHALAN; REACTIVE OXYGEN METABOLITE;

ANALYTIC METHOD; ARTICLE; BIOASSAY; CELL GROWTH; CELL HYPOXIA; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHEMOSENSITIZATION; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INTRACELLULAR SPACE; NEUROBLASTOMA; NEUROBLASTOMA CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REDUCTION KINETICS; STATISTICAL SIGNIFICANCE;

ANTINEOPLASTIC AGENTS, ALKYLATING; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; FLOW CYTOMETRY; GLUTAMINE; GLUTATHIONE; HUMANS; MELPHALAN; NEUROBLASTOMA; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES;

EID: 43449095001     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-007-0338-2     Document Type: Article

References (27)

1. Anderson CP, Tsai JM, Chan W, Park CK, Tian L, Lui RM, Forman HJ, Reynolds CP (1997) Buthionine sulfoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines. Eur J Cancer 33:2016-2019
2. Anderson CP, Seeger RC, Matthay KK et al (1998) Pilot study of buthionine sulfoximine (BSO) and melphalan (L-PAM) in children with recurrent neuroblastoma. Proc Am Soc Clin Oncol 17:531
3. Anderson CP, Tsai JM, Meek WE, Liu RM, Tang Y, Forman HJ, Reynolds CP (1999) Depletion of glutathione by buthionine sulfoxine is cytotoxic for human neuroblastoma cell lines via apoptosis. Exp Cell Res 246:183-192
4. Benlloch M, Mena S, Ferrer P, Obrador E, Aseni M, Pellicer JA, Carretero J, Ortega A, Estrela JM (2006) Bcl-2 and Mn-SOD antisense oligodeoxynucleotides and a glutamine-enriched diet facilitate elimination of highly resistant B16 melanoma cells by tumor necrosis factor- and chemotherapy. J Biol Chem 281:69-79
5. Carretero J, Obrador E, Pellicer JA, Pascual A, Estrela JM (2000) Mitochondrial glutathione depletion by glutamine in growing tumor cells. Free Radical Biol Med 29:913-923
6. Chang WK, Yang KD, Shaio MF (1999) Lymphocyte proliferation modulated by glutamine: involved in the endogenous redox reaction. Clin Exp Immunol 117:482-488
7. Curi R, Lagranha CJ, Doi SQ, Sellitti DF, Procopio J, Pithon-Curi TC (2005) Glutamine-dependent changes in gene expression and protein activity. Cell Biochem Funct 23:77-84
8. Fernandes RS, Cotter TG (1994) Apoptosis or necrosis: intracellular levels of glutathione influence mode of cell death. Biochem Pharmacol 48:675-681
9. Frenkel K, Gleichauf C (1991) Hydrogen peroxide formation by cells treated with a tumor promoter. Free Radic Res Commun 12-13(Pt 2):783-794
10. Fuchs BC, Bode BP (2006) Stressing out over survival: glutamine as an apoptotic modulator. J Surg Res 131:26-40
11. Green JA, Vistica DT, Young RC, Hamilton TC, Rogan AM, Ozols RF (1984) Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion. Cancer Res 44:5427-5431
12. Gurney JG, Ross JA, Wall DA, Bleyer WA, Severson RK, Robison LL (1997) Infant cancer in the U.S.: histology-specific incidence and trends, 1973 to 1992. J Pediatr Hematol Oncol 19:428-443
13. Herrlich P, Bohmer FD (2000) Redox regulation of signal transduction in mammalian cells. Biochem Pharmacol 59:35-41
14. Jögi A, Øra I, Nilsson H, Lindeheim A, Makino Y, Poellinger L, Axelson H, Påhlman S (2002) Hypoxia alters gene expression in human neuroblastoma cell lines toward an immature and neural crest-like phenotype. Proc Natl Acad Sci USA 99:7021-7026
15. Jögi A, Øra I, Nilsson H, Poellinger L, Axelson H, Påhlman S (2003) Hypoxia-induced dedifferentiation in neuroblastoma cells. Cancer Lett 197:145-150
16. Kang YJ (1993) Buthionine sulfoximine spares intracellular glutamate: a possible mechanism for cell growth stimulation. Cell Mol Biol Res 39:675-684
17. Kang YJ, Freng Y, Hatcher EL (1994) Glutathione stimulates A549 cell proliferation in glutamine-deficient culture: the effect of glutamate supplementation. J Cell Physiol 161:589-596
18. Meister A (1991) Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol Ther 51:155-194
19. Neu J, Shenoy V, Chakrabarti R (1996) Glutamine nutrition and metabolism: where do we go from here? FASEB J 10:829-837
20. Oehler R, Roth E (2003) Regulative capacity of glutamine. Curr Opin Clin Nutr Metab Care 6:277-282
21. Roth ER, Oehler R, Manahart N, Exner R, Wessner B, Strasser E, Spittler A (2002) Regulative potential of glutamine-relation to glutathione metabolism. Nutrition 18:217-221
22. Schroder CP, Godwin AK, O'Dwyer PJ, Tew KD, Forman HJ, Reynolds CP (1996) Glutathione and drug resistance. Cancer Investig 14:158-168
23. Soh H, Wasa M, Wang HS, Fukuzawa M (2005) Glutamine regulates acid transport and glutathione levels in a human neuroblastoma cell line. Pediatr Surg Int 21:29-33
24. Tew KD, Houghton PJ, Houghton JA (1993) Preclinical and clinical modulation of anticancer drugs. CRC, Boca Raton, pp 13-17
25. Todorova VK, Harms SA, Kaufmann Y, Luo S, Luo KO, Babb K, Klimberg VS (2004) Effect of dietary glutamine on tumor glutathione levels and apoptosis-related proteins in DMBA-induced breast cancer of rats. Breast Cancer Res Treat 88:247-256
26. Vandeputte C, Guizon I, Genestie-Denis I, Vannier B, Lorenzon G (1994) A microtiter plate assay for total glutathione and glutathione disulfide contents in cultured/isolated cells: performance study of a new miniaturized protocol. Cell Biol Toxicol 10:415-421
27. Wasa M, Bode BP, Abcouwer SF, Collins CL, Tanabe KK, Souba WW (1996) Glutamine as a regulator of DNA and protein biosynthesis in human solid tumor cell lines. Ann Surg 224:189-197